|
Volumn 7, Issue 1, 2006, Pages 87-89
|
Personalizing medicine: The single nucleotide polymorphism and the treatment of status asthmaticus
|
Author keywords
adrenergic receptor; Asthma; Haplotype; Single nucleotide polymorphism
|
Indexed keywords
ADENYLATE CYCLASE;
ADRENERGIC RECEPTOR;
AMINO ACID;
AMINOPHYLLINE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CYCLIC AMP;
DNA;
GLUTAMIC ACID;
GLUTAMINE;
GUANINE NUCLEOTIDE BINDING PROTEIN;
MESSENGER RNA;
NUCLEOTIDE;
PROTEIN;
SALBUTAMOL;
STEROID;
ALLELE;
AMINO ACID SEQUENCE;
ASTHMATIC STATE;
DNA SEQUENCE;
EDITORIAL;
ENZYME ACTIVITY;
GENETIC POLYMORPHISM;
GENETIC TRANSCRIPTION;
GENETIC VARIABILITY;
GENOME;
GENOTYPE;
HAPLOTYPE;
HOSPITAL ADMISSION;
HOSPITALIZATION;
HUMAN;
HYBRIDIZATION;
INTENSIVE CARE UNIT;
PEDIATRICS;
PHENOTYPE;
POINT MUTATION;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROTEIN STRUCTURE;
SINGLE NUCLEOTIDE POLYMORPHISM;
ADRENERGIC BETA-AGONISTS;
AFRICAN AMERICANS;
AMINOPHYLLINE;
CHILD;
DRUG THERAPY, COMBINATION;
HAPLOTYPES;
HUMANS;
PHOSPHODIESTERASE INHIBITORS;
POLYMORPHISM, SINGLE NUCLEOTIDE;
RECEPTORS, ADRENERGIC, BETA-2;
STATUS ASTHMATICUS;
|
EID: 33646117765
PISSN: 15297535
EISSN: None
Source Type: Journal
DOI: 10.1097/01.PCC.0000194002.89906.42 Document Type: Editorial |
Times cited : (1)
|
References (11)
|